esophageal cancer

Experts support FDA's plan for restrictions on PD-1 drugs in stomach, esophageal cancers
Fierce Pharma
Thu, 09/26/24 - 06:35 pm
FDA
regulatory
PD-1 inhibitors
stomach cancer
gastric cancer
esophageal cancer
Exact Sciences posts positive data for its capsule-on-a-string test for esophageal cancer
Fierce Biotech
Thu, 03/28/24 - 11:44 am
EXACT Sciences
esophageal cancer
Medtech
diagnostics
capsule-on-a-string
Barrett's esophagus
FDA Indefinitely Delays BeiGene/Novartis anti-PD-1 Esophageal Cancer Drug
BioSpace
Thu, 07/14/22 - 10:51 am
Novartis
BeiGene
FDA
tislelizumab
esophageal cancer
Novartis records another tislelizumab win en route to bringing BeiGene's PD-1 to FDA's doors
Endpoints
Wed, 04/27/22 - 10:32 am
Novartis
BeiGene
tislelizumab
esophageal cancer
First FDA filing for Novartis’ latecomer PD-1 drug tislelizumab
Pharmaforum
Mon, 09/13/21 - 10:26 am
Novartis
tiselizumab
FDA
esophageal cancer
BeiGene
Bristol Myers' Opdivo leads the pack with FDA approval for resected esophageal or GEJ cancer
Endpoints
Fri, 05/21/21 - 11:48 am
Bristol Myers Squibb
Opdivo
FDA
esophageal cancer
gastroesophageal cancer
Bristol Myers' Opdivo notches a double win against chemo in esophageal cancer, potentially setting up 1st-line nod
Endpoints
Thu, 04/8/21 - 11:12 am
Bristol Myers Squibb
Opdivo
clinical trials
esophageal cancer
Could Opdivo be a New Standard in Esophageal Cancer Therapy?
BioSpace
Fri, 04/2/21 - 10:50 am
Bristol Myers Squibb
Opdivo
esophageal cancer
Merck Scores Latest Label Expansion for Keytruda in Esophageal Carcinomas
BioSpace
Tue, 03/23/21 - 11:23 pm
Merck
Keytruda
esophageal cancer
FDA
BeiGene’s Tislelizumab Improves Survival in Esophageal Cancer Study
BioSpace
Thu, 01/28/21 - 11:10 pm
BeiGene
monoclonal antibodies
tislelizumab
clinical trials
esophageal cancer
FDA grants priority review to KEYTRUDA for treatment of esophageal and gastroesophageal junction cancer
Pharmaceutical Business Review
Fri, 12/18/20 - 10:50 am
Merck
Keytruda
FDA
esophageal cancer
gastroesophageal cancer
#ESMO20: Bristol Myers marks Opdivo's second adjuvant win — eyeing a standard of care gap
Endpoints
Mon, 09/21/20 - 11:27 pm
Bristol-Myers Squibb
ESMO
Opdivo
esophageal cancer
Merck's Keytruda sets up Opdivo showdown with esophageal cancer victory
Fierce Pharma
Thu, 08/20/20 - 10:48 am
Merck
Opdivo
esophageal cancer
Bristol Myers Squibb’s Opdivo Hits Mark in Two Phase III Studies
BioSpace
Wed, 08/12/20 - 12:31 am
Bristol-Myers Squibb
Opdivo
clinical trials
gastric cancer
esophageal cancer
Merck's Keytruda makes the cut as a second-line monotherapy for certain esophageal cancer patients
Endpoints
Wed, 07/31/19 - 10:06 am
Merck
Keytruda
esophageal cancer
Merck's Keytruda slashes death risk by 31% in esophageal cancer victory
Fierce Pharma
Tue, 01/15/19 - 12:02 am
Merck
Keytruda
esophageal cancer
Opdivo meets OS endpoint in esophageal cancer trial
BioCentury
Wed, 01/9/19 - 07:24 pm
Ono Pharmaceutical
Opdivo
esophageal cancer
Bristol-Myers Squibb
Merck's Keytruda picks up first-in-class survival win in esophageal cancer
Fierce Pharma
Wed, 11/14/18 - 11:55 am
Merck
Keytruda
esophageal cancer
A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer
Forbes
Mon, 06/20/16 - 10:18 am
ASCO 2016
Claudiximab
antibodies
Ganymed
stomach cancer
esophageal cancer
Patients With Advanced Breast, Lung, Esophageal, and Colorectal Cancers Respond to Immunomedics' Novel Antibody-Directed Chemotherapy After Failing Multiple Prior Standard Treatments
Yahoo
Mon, 04/20/15 - 05:15 pm
Immunomedics
chemotherapy
breast cancer
lung cancer
esophageal cancer
colorectal cancer
sacituzumab govitecan

Pages